top of page

Can Trial Pricing work in Logistics & Supply Chain Technology with operational risk?

Logistics software gets purchased after a costly failure, so a trial should resolve an actual shipment, inventory or hiring workflow rather than show a feature list. Veeqo gives sellers free core shipping functionality and sells additional inventory capability; Tenstreet uses tailored enterprise pricing based on fleet and recruiting scope. Neither proves a fixed-duration Trial Pricing offer here. A warehouse that connects one channel may still suffer overselling elsewhere; a carrier cannot assess driver compliance from a fabricated application.

See how top HealthTech companies found a payer and built recurring revenue, in Business Core.

✓ Skip the success story. Get the decisions behind it  ✓ Not a case study. A teardown you can copy from.

Business Core breaks down top HealthTech companies' revenue models, pricing, buyers and revenue risks, so you can see who pays, how they buy and where revenue is exposed.

40 Foundational Decisions

34 Model Frameworks

80 Strategy Patterns

4 Pillars of any Business

Backed by evidence
On which a company is built on
Of proven growth & expansion 
Model · Market · Money · Motion

✓ Find relevant precedents in under 2 minutes   ✓ Updated every 6 months    ✓ 6 ARR stages, from pre-$1M to $100M+

Pick a decision or a strategy.
Go deep on companies that made it

Your exact comparables, one filter away.

The companies you study didn't build by instinct alone.
Neither should you.

Stop studying companies that never faced your call.
Famous case studies won’t fit your decision. These will.

​

With a Situation or Strategy you need insight on

​

Open results to see exactly how they did it - and how you can do the same.​

​

The framework walks you through every layer of how the company was built, grown & sustained big

Product & Business Model Decision
Business Model

Airwallex

Scrivener / Literature & Latte

Auth0

SocialPilot

Box

Twilio

Revolution Brewing

MeetingPlay

Cuvva

Fivetran

Zoho

Intercom

Thriver

✓ Get the Full list of companies under each   ✓ Unlock in-depth intel on each company
From “what should we do?” to a written plan in one sitting

DISTRIBUTION MODEL

Why is it harder to find a reliable payer for recurring revenue in HealthTech?

Because healthcare splits the user, the payer and the decision-maker. Clinicians use the product, insurers or health systems pay, pharmaceutical brands buy attention and patients often pay nothing. Regulation on privacy, advertising and clinical AI adds constraints. A predictable model starts by naming one payer who feels the pain and has a budget. I'd write down, in one line, who signs the cheque and who feels the pain, and be suspicious if they're different people with no budget link.

How do HealthTech companies decide who pays for the product?

• Ask who has a budget line for the problem. Doximity found it in pharmaceutical marketing and health-system hiring, not in clinicians.

• Charge the practitioner when the product replaces their own admin work, as SimplePractice does with a per-clinician price.

• Keep the free side free if the free side creates the value. Doximity keeps clinician-side tools free to maintain engagement and trust.

• Scale price by the number of clinicians and feature depth, so a growing practice pays more without renegotiating.

• Write down what happens if the payer's budget is cut, so you know which customers are exposed.

• Map the money flow on one page: who uses, who approves, who pays and who is affected, and sell to the person who pays.

Which HealthTech companies priced by clinician, by audience or by contract?

These are same-industry precedents, not exact matches.

• SimplePractice: Starter at $49 a month, Essential at $79 and Plus at $99 for the first clinician, with additional practitioners at $37 to $74 a month and claims beyond limits at $0.25 to $0.50 each.

• Doximity: quote-based enterprise pricing for Marketing, Hiring and Workflow Solutions based on audience access, campaign scope and product usage.

• ADP (HR precedent): RUN payroll for businesses under 50 employees, with market references of about $59 to $79 a month plus per-employee fees, and quote-based Workforce Now.

• The unit in each case is something the payer already counts: clinicians, audience reach or employees.

What did Doximity and SimplePractice show to prove their HealthTech revenue was recurring?

Doximity reported subscription revenue of $543.8 million in FY2025 and 119% net revenue retention in Q4 FY2025. SimplePractice shows a per-clinician subscription structure but doesn't disclose ARR. As a cross-industry precedent, Oracle reported that cloud services and licence support produced $44.0 billion, 76.7% of its FY2025 revenue. Retention and recurring share are the two numbers that travel.

What numbers should a HealthTech founder show to prove recurring revenue?

• Shipments completed with correct inventory deduction.


• Verification time for a qualified driver application.


• Use a contained operational lane: one channel-to-shipment flow or one verified driver application, with a rollback path and signed success criteria.

What revenue and retention figures did Doximity, ADP and Oracle publish as HealthTech precedents?

Two are from other industries and are marked as such.

• Doximity (HealthTech): subscription revenue of $543.8 million in FY2025 and net revenue retention of 119% in Q4 FY2025.

• ADP (HR precedent): FY2025 revenue of $20.6 billion, Employer Services retention of 92.1% and no client above 2% of revenue.

• Oracle (HR precedent): FY2025 total revenue of $57.4 billion, with 76.7% from cloud services and licence support.

Free for clinicians or paid by clinicians: which HealthTech payer model did each company choose?

Doximity made the clinician side free and sold access to the audience. SimplePractice made the clinician the payer. Both give recurring revenue, but they carry different risks: concentration in a few pharmaceutical buyers on one side, and commoditisation and small-practice churn on the other. I'd choose the clinician as payer if your product removes work they feel weekly, and the audience model only if you already have a trusted, active professional network.

Should a HealthTech startup monetise the audience or the practitioner?

• Monetise the audience if you have scale and trust.

• Monetise the practitioner if the product removes admin work they feel every week.

• Avoid monetising too early if member trust isn't established.

• Test willingness to pay with a 30-day trial, as SimplePractice does.

• Keep the unit simple: clinicians, not features.

• Check how often the payer must justify the spend. A product tied to a recurring clinical or billing task will survive budget review better than a reporting tool.

Which HealthTech companies relied on subscriptions from practitioners and which from enterprises?

Two models, two payers.

• SimplePractice: a 30-day trial then subscriptions by clinician count and feature depth.

• Doximity: enterprise subscriptions sold to pharmaceutical manufacturers and health systems.

• Both show recurring revenue without charging the patient.

How to build a predictable revenue model in HealthTech

Identify the payer, price a unit they already count, and sell on subscription. The first decision is whether you charge clinicians, organisations or brands. The condition that decides the path is whether the payer's trust and your compliance record hold up under review. If privacy or accuracy is in doubt, don't monetise yet.

Business Core shows each company's revenue model, pricing, buyers and how-to-copy steps, so you can see who pays in healthcare and how contracts are structured.

Check the revenue risks and cautions behind each model in Business Core, such as compliance risk and payer concentration, before you set pricing.

1-model (6).png

Which HealthTech risks can undermine recurring revenue after the first contract?

Customer concentration, privacy and advertising scrutiny, AI accuracy and liability and commoditisation by AI-native tools. Each can slow renewals or cap price. Concentration and trust are the two I'd read first, because both hit at once if a large brand pulls budget or a clinician loses confidence in your data handling.

How do HealthTech vendors protect recurring revenue from compliance and AI risk?

• Build HIPAA and privacy compliance into the product from the start.

• Govern AI features with auditability and clinical accuracy checks.

• Spread revenue across more buyers.

• Make billing reliable, because failure drives churn.

• Watch telehealth and platform dependency.

• Document clinical accuracy tests and keep humans in the loop for any AI documentation or clinical suggestion.

What revenue risks did Doximity and SimplePractice name in HealthTech?

Different payers, different risks.

• Doximity: pharmaceutical marketing concentration, regulatory and privacy scrutiny, AI liability and accuracy risk and competition from Sermo and LinkedIn.

• SimplePractice: commoditization from TherapyNotes, Sessions Health and AI-native EHR tools, HIPAA and payer-rule compliance, telehealth dependency and intense price pressure.

• Read these lists as a reminder that healthcare risk is usually about trust and regulation before it is about competition.

How do HealthTech buyers decide to pay for a platform?

A practitioner starts when administrative burden or billing complexity hurts, finds a tool through search or community and starts a trial. A pharmaceutical brand or health system starts from a need for clinician reach, recruitment or workflow modernisation, then marketing, IT and compliance leaders assess audience quality, engagement and integration. Privacy and security reviews come before pricing for organisations, so have the documents ready before the first call.

What do HealthTech buyers check before they commit to a subscription?

• A free trial long enough to run a real billing cycle.

• Privacy, security and compliance evidence.

• Audience quality for brands.

• Integration with their existing systems.

• Support when something fails.

• Offer data export and migration support, since practitioners worry about being locked in with patient records.

How did buyers of SimplePractice and Doximity purchase in HealthTech?

Two buyers, two routes.

• SimplePractice: a practitioner identifies administrative burden, discovers it through search or community, starts a 30-day trial, then adopts by clinician count and feature needs.

• Doximity: a pharmaceutical brand or health system evaluates after a need for clinician reach, recruitment or workflow modernization; marketing and IT leaders assess audience quality, compliance and integration.

• The practitioner route takes days to weeks, while the brand and health-system route takes longer and involves compliance review.

What did HealthTech founders get wrong while trying to monetise?

They monetised the audience before building trust, shipped clinical AI without governance or depended on one integration for the core workflow. Each of these cost trust, and in healthcare trust is the only thing that lets a recurring price survive.

What HealthTech monetisation mistakes erode clinician trust before revenue becomes recurring?

• Don't copy enterprise monetisation before member trust is established.

• Don't ship AI clinical tools without governance.

• Don't depend on one integration for the core workflow.

• Don't offer unlimited free usage if costs outrun conversion.

• Don't copy global breadth without compliance depth.

• Don't promise clinical outcomes you haven't validated.

Which cautions did Doximity, SimplePractice and ADP carry as HealthTech and cross-industry precedents?

Each caution protects trust.

• Doximity's caution: do not copy enterprise monetization before member trust is established, and avoid AI clinical tools without governance.

• SimplePractice's caution: do not depend on one integration for the core workflow, and do not offer unlimited free usage if infrastructure and support costs scale faster than conversion.

• ADP's caution (HR precedent): do not copy global breadth without jurisdictional compliance depth.

Enter business core

Does Business Core show how companies priced their products?

Yes. The Monetization pillar covers each company's revenue model, pricing, who pays, how they buy and the revenue risks.

Does Business Core explain who pays and how they buy?

Reliable recruiting or verification under the carrier’s real operating requirements.

Does Business Core show which risks put revenue in danger?

Yes. The Monetization pillar lists each company's revenue risks, and the Model pillar adds the pits, traps and moves that need caution.

Does Business Core show the founder decision behind each pillar?

Yes. Each pillar opens with the founder decision the company faced and the evidence behind its choice.

Business Core
Everything You Need To Build a Winning Business

Own the
playbook of companies 

that won

One-time payment · No subscription · No seat fees

Lifetime Access

Business Core

$180

180

​

​

Valid until canceled

SSL Secure Checkout. Instant access.

Companies broken down on the same 56 fields 

Filter by 40 decisions carried out by SAAS Cos.

114 model & strategy labels executed by Top Cos.

See what worked, failed and why

Leave with an ARR-stage replication blueprint

Turn proven patterns into your own strategy

​​​​

Your Business Core access is automatically added to your account on purchase.

The strategic intelligence gap closes the moment you open it.

Walk in with the decision; Walk out with companies that already made it - Here's what's INCLUDED :

MODEL

• Business Models  • Distribution Model  • Model Insights  • How to Apply it  • Opportunities & Risks

MARKET

• Market Type  • Market Entry & Foothold Strategy  • Growth Model  • Market Intelligence  • Playbook

​

MONETIZATION

• Revenue & Pricing Model  • Target Audience  • Customer Buying Behaviour  • Patterns  • Pricing Intel

MOTION

• Competitive Strategy  • Growth & Expansion Strategy • GTM Summary  • Growth Engine  • Sustaining Moats

​

bottom of page